Clin2
NCT05837104Possibly a fitRecruiting

Magnesium and vitamin B6 for early bipolar depression

Bipolar I DisorderDepression, AnxietyStress

Part of Mental health clinical trials.

This Phase 2 trial tests whether magnesium plus vitamin B6 can reduce depressive symptoms in people who are newly diagnosed with bipolar I disorder. It also checks for safety over a short, 4-week treatment period.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You’re between 18 and 50 years old
  • You have bipolar I disorder, diagnosed within the last 10 years
  • Your depression and symptom scores match the study targets, and you’re not too manic (YMRS under 15)
  • Your bipolar treatment plan is stable: no medication changes in the past 2 weeks, and no new psychiatric meds expected during the 4 weeks
  • You can sign informed consent and agree to take part for 4 weeks
  • Your weight is 350 lbs or less

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05977023Recruiting· Phase 2
NMDA-targeted medicine to treat bipolar I depression

This Phase 2 study tests a medication that works on NMDA receptors to improve depression symptoms in people with bipolar I disorder. It may help if you’re currently in a bipolar depression episode and other mood treatments haven’t fully controlled it.

Taichung
NCT07494305Recruiting· Phase 2
Testing a new drug for bipolar depression

This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.

Bentonville, Arkansas
NCT07172516Recruiting· Phase 3
Study of azetukalner vs placebo for bipolar depression

This trial tests whether the study drug azetukalner can help reduce depression symptoms in people with bipolar I or II disorder who are currently having a depressive episode. You would be randomly assigned to receive either the drug or a placebo (inactive pill) to see which works better.

Tucson, Arizona
NCT05457465Recruiting· Phase 2
Cannabidiol study for anxiety and depression in bipolar disorder

This Phase 2 study tests whether cannabidiol (CBD) can reduce anxiety and depressive symptoms in people with bipolar disorder. It may help if your mood symptoms are persistent and you’re already on stable bipolar medications.

Belmont, Massachusetts
NCT07633080Recruiting
Magnesium supplement added to antidepressants for depression

This study tests whether adding magnesium bisglycinate (a mineral supplement) to your current antidepressant medication can help improve depression symptoms. Researchers want to see if this combination works better than antidepressant alone.

Bhubaneswar, Odisha
NCT07469462Recruiting
High-dose vitamin B6 for depression and anxiety

This study tests whether high doses of vitamin B6 can help reduce symptoms of anxiety and depression. If you have mild to moderate anxiety or depression, you may be able to participate.

Reading, England

Hear when a new Bipolar I Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.